SSG
TECH icon

Summit Securities Group’s Bio-Techne TECH Stock Holding History

Summit Securities Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$1.91M – 864
2021
Q1 		$1.91M Buy
+200
New +$18.2K 0.21% 107

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Summit Securities Group's TECH Position: Q2 2026 in Review

Summit Securities Group increased its Bio-Techne (TECH) stake by 504% in Q2 2026, buying an estimated $7.07K and bringing the position to 157 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #821.

Summit Securities Group first reported a position in TECH in Q1 2021 and has held it in 13 quarters since. The position peaked at $401K in Q1 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Summit Securities Group held 157 shares of Bio-Techne worth $11.1K as of Q2 2026.
  • Summit Securities Group bought 131 Bio-Techne shares in Q2 2026, an estimated $7.07K.
  • Bio-Techne made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #821 holding.
  • Summit Securities Group first reported a position in Bio-Techne in Q1 2021 and has held it in 13 quarters since.
  • Summit Securities Group's Bio-Techne position peaked at $401K in Q1 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.